OBJECTIVES: Adherence is critical for maximizing the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV infection. Strategies for promoting adherence to HIV treatment, and their potential application to PrEP adherence, have received considerable attention. However, adherence promotion strategies for prevention medications have not been well characterized and may be more applicable to PrEP. We aimed to identify adherence support interventions that have been effective in other prevention fields and could be applied in the HIV prevention context to support pill taking among PrEP users. METHODS: To identify adherence support interventions that could be evaluated and applied in the PrEP context, we conducted a systematic review across the following prevention fields: hypertension, latent tuberculosis infection, hyperlipidaemia, oral contraceptives, osteoporosis, malaria prophylaxis, and post-exposure prophylaxis for HIV infection. We included randomized controlled trials that evaluated the efficacy of interventions to improve adherence to daily oral medications prescribed for primary prevention in healthy individuals or for secondary prevention in asymptomatic individuals. RESULTS: Our searches identified 585 studies, of which 48 studies met the eligibility criteria and were included in the review; nine evaluated multiple strategies, yielding 64 separately tested interventions. Interventions with the strongest evidence for improving adherence included complex, resource-intensive interventions, which combined multiple adherence support approaches, and low-cost, low-intensity interventions that provided education or telephone calls for adherence support. CONCLUSIONS: Our review identified adherence interventions with strong evidence of efficacy across prevention fields and provides recommendations for evaluating these interventions in upcoming PrEP studies.
OBJECTIVES: Adherence is critical for maximizing the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV infection. Strategies for promoting adherence to HIV treatment, and their potential application to PrEP adherence, have received considerable attention. However, adherence promotion strategies for prevention medications have not been well characterized and may be more applicable to PrEP. We aimed to identify adherence support interventions that have been effective in other prevention fields and could be applied in the HIV prevention context to support pill taking among PrEP users. METHODS: To identify adherence support interventions that could be evaluated and applied in the PrEP context, we conducted a systematic review across the following prevention fields: hypertension, latent tuberculosis infection, hyperlipidaemia, oral contraceptives, osteoporosis, malaria prophylaxis, and post-exposure prophylaxis for HIV infection. We included randomized controlled trials that evaluated the efficacy of interventions to improve adherence to daily oral medications prescribed for primary prevention in healthy individuals or for secondary prevention in asymptomatic individuals. RESULTS: Our searches identified 585 studies, of which 48 studies met the eligibility criteria and were included in the review; nine evaluated multiple strategies, yielding 64 separately tested interventions. Interventions with the strongest evidence for improving adherence included complex, resource-intensive interventions, which combined multiple adherence support approaches, and low-cost, low-intensity interventions that provided education or telephone calls for adherence support. CONCLUSIONS: Our review identified adherence interventions with strong evidence of efficacy across prevention fields and provides recommendations for evaluating these interventions in upcoming PrEP studies.
Authors: Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden Journal: N Engl J Med Date: 2010-11-23 Impact factor: 91.245
Authors: Norma C Ware; Monique A Wyatt; Jessica E Haberer; Jared M Baeten; Alexander Kintu; Christina Psaros; Steven Safren; Elioda Tumwesigye; Connie L Celum; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2012-04-15 Impact factor: 3.731
Authors: Michelle E Roland; Torsten B Neilands; Melissa R Krone; Thomas J Coates; Karena Franses; Margaret A Chesney; James S Kahn; Jeffrey N Martin Journal: Clin Infect Dis Date: 2011-07-01 Impact factor: 9.079
Authors: David J Magid; P Michael Ho; Kari L Olson; David W Brand; Lesley K Welch; Karen E Snow; Anne C Lambert-Kerzner; Mary E Plomondon; Edward P Havranek Journal: Am J Manag Care Date: 2011-04 Impact factor: 2.229
Authors: Arunrat Tangmunkongvorakul; Suwat Chariyalertsak; K Rivet Amico; Pongpun Saokhieo; Vorawan Wannalak; Thirayut Sangangamsakun; Pedro Goicochea; Robert Grant Journal: AIDS Care Date: 2012-12-19
Authors: Darrell H S Tan; Mark W Hull; Deborah Yoong; Cécile Tremblay; Patrick O'Byrne; Réjean Thomas; Julie Kille; Jean-Guy Baril; Joseph Cox; Pierre Giguere; Marianne Harris; Christine Hughes; Paul MacPherson; Shannon O'Donnell; Joss Reimer; Ameeta Singh; Lisa Barrett; Isaac Bogoch; Jody Jollimore; Gilles Lambert; Bertrand Lebouche; Gila Metz; Tim Rogers; Stephen Shafran Journal: CMAJ Date: 2017-11-27 Impact factor: 8.262
Authors: Alisse Hannaford; Madeleine Lipshie-Williams; Joanna L Starrels; Julia H Arnsten; Jessica Rizzuto; Phillip Cohen; Damon Jacobs; Viraj V Patel Journal: AIDS Behav Date: 2018-04
Authors: Sarah Wood; Robert Gross; Judy A Shea; José A Bauermeister; Joshua Franklin; Danielle Petsis; Meghan Swyryn; Linden Lalley-Chareczko; Helen C Koenig; Nadia Dowshen Journal: AIDS Behav Date: 2019-10
Authors: Derin Sevenler; Ashley Bardon; Marta Fernandez Suarez; Lisa Marshall; Mehmet Toner; Paul K Drain; Rebecca D Sandlin Journal: ACS Infect Dis Date: 2020-05-14 Impact factor: 5.084
Authors: Audrey Pettifor; Nadia L Nguyen; Connie Celum; Frances M Cowan; Vivian Go; Lisa Hightow-Weidman Journal: J Int AIDS Soc Date: 2015-02-26 Impact factor: 5.396